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Abstract: The non-medical use of pharmaceuticals, which is defined as the intentional intake 
of medication that is not medically necessary, has become recognised as a public health 
problem. Many women engaged in non-medical prescription use suffer concurrent mental 
health problems, often associated with the current and/or past exposure to violence in the 
home. In these cases, complex clinical presentations are to be entangled, with reports that the 
substances are used as a coping mechanism, particularly, when sexual violence is part of the 
victimisation history. This article provides insight into the complex interplay between 
victimisation experiences, mental health problems and substance use as well as the increased 
recognition of the danger of accidental overdoses. It demonstrates the importance of flexible 
multidisciplinary support from specialist services for clients who present with multiple 
comorbidities and vulnerabilities. As such, the article advocates for multidisciplinary 
management, which allows assisting women with complex presentations utilising 
collaborative care provided by an interdisciplinary team. 
 
 






Opioid analgesics, when taken as prescribed, assist pain management of countless 
sufferers in a safe way. This is the reason why certain medications require 
prescriptions by medical professionals who oversee the management of health 
conditions with pharmaceutical intervention. Prescription drugs are regulated by 
legislation because they can cause harm to the user if taken differently than 
prescribed by a medical practitioner (Bell & Salmon, 2009). If prescription 
medications are used for non-medical purposes, numerous health risks may occur 

















The use of pharmaceuticals for non-medical purposes (prescription and over-the-
counter available substances), defined as the intentional intake of medication that is 
not medically necessary (Guggisberg, 2010) has recently been recognised as a 
public health problem (National Institute on Drug Abuse, 2011). The danger of any 
psychoactive substance is that even a ‘one off’ dose may result in respiratory 
complications and even death (National Institute on Drug Abuse, 2011). Recently, 
the Centers for Disease Control and Prevention (2011) referred to an ‘epidemic of 




Non-medical use of pharmaceuticals 
 
There is a problem that needs to be recognised to reduce the prevalence of fatal 
overdoses with prescription medication. In the United States, ‘one hundred people 
die from drug overdoses every day’, the Centers for Disease Control and 
Prevention (2011) reported. Over 36,000 people died from drug overdoses in 2008, 
mostly caused by prescription medication, which is a three-fold increase since 
1990. 
 
There are different classes of prescription drugs that are used non-medically, such 
as strong painkillers (opioid-analgesics), benzodiazepines (minor-tranquillisers), 
and amphetamine-type stimulant medications (Australian Institute of Health and 
Welfare, 2011). Opioid analgesics are pain relievers that include real or synthetic 
ingredients of the opium poppy plant (e.g., Fentanyl, Oxycodone). Benzodiazepines 
are central nervous system depressants. 
 
Opioid analgesics 
Opioids reduce pain signals to the brain and inhibit painful stimuli with the effect 
of inhibited or reduced experiences of pain. Medications prescribed have distinct 
pain relieving properties such as Morphine or Oxycodone, as these drugs attach to 
opioid receptors in the brain and block the pain stimulus. 
 
Minor Tranquilisers 
Central nervous system depressants slow the brain activity and produce a calming 
effect. Benzodiazepines are commonly prescribed for anxiety-related symptoms 
and/or sleep disorders such as Xanax and or Diazepam. Usually, they are prescribed 
for short-term management of symptoms to avoid development of tolerance and 










   
 
   
   
 
   
   
 
   
        
 
    
 
 
   
   
 
   
   
 
   
       
 
Amphetamine-type Medications 
Central nervous system stimulants increase a person’s heart rate, blood pressure 
and respiration. As a consequence, cognitive enhancement is experienced with 
increased attention, alertness and energy. Medication such as Ritalin is prescribed 
for a condition called Attention Deficit Hyperactivity Disorder, which has been 
proven to be beneficial. 
 
 
Trends in non-medical prescription drug use 
 
The proportions of non-medical pharmaceuticals use with the exception of alcohol, 
tobacco and cannabis, are higher than any other substance (Australian Institute on 
Health and Welfare, 2011; National Institute on Drug Abuse, 2011). In Australia, 
the prevalence of non-medical use of pharmaceutics has been estimated over 4% 
(see Table 1).  
 
Research indicates that painkillers/analgesics are used most often non-medically, 
followed by tranquillisers/sleeping pills (Australian Institute of Health and Welfare, 
2011; Centers of Disease Control and Prevention, 2011). While the potential for 
non-medical use of central nervous system stimulants, prescribed to treat 
depression, attention-deficit-hyperactivity disorder and narcolepsy, has been noted, 
these pharmaceutics are least likely to be used non-medically (National Institute on 
Drug Abuse, 2011). 
 
According to the results of the 2010 National Drug Strategy Household Survey 
Report (Australian Institute of Health and Welfare, 2011), around 10% of the 
Australian population used prescription medication for non-medical purposes in 
their lifetime. The highest prevalence was found to be among individuals aged 
between 20 and 39 years. People were most likely to use prescription medications 
belonging to the category of painkillers/analgesics, with a higher rate for females 
when compared to males (31% vs. 24%). More than 1/3 of females reported using 
these medications non-medically daily or weekly. Again, a gender disparity was 
observed with ¼ of males using pharmaceuticals for non-medical purposes 



















  Source: AIHW, 2011 
 
 
A similar pattern was reported in the United States where women were identified 
as a particular vulnerable group according to the latest data from the 2010 
National Survey on Drug Use and Health (National Institute on Drug Abuse, 
2011). Apart from age, research has found other demographic factors that were  
associated with the use of female pharmaceutics. Some consistent findings were 
reported with regard to minority status, suggesting that Caucasian women were 
more likely than minority women to use prescription drugs non-medically (Arkes 
& Iguchi, 2008). Furthermore, a negative correlation with income was reported, 
as well as education level, which seems to be a protective factor. In addition, 
women not participating in the labour force were found to have a higher 
prevalence of non-medical prescription drug use when compared to those working 
for payment (Arkes & Iguchi). Finally, mixed results were found with regard to 
status of relationship. Arkes and Iguchi (2008) found no association with 
relationship status, which was not what they expected. In their study, examining 
painkiller use, married women aged 18-25 had a lower prevalence than married 
women aged 26-34 years. These findings indicated a need for further research. 
 
Caucasian women, with lower education, not participating in the workforce and 
not married have been found to be associates for non-medical use of prescription 
medication (Arkes & Iguchi, 2008). Income was also negatively correlated with 






   
 
   
   
 
   
   
 
   
        
 
    
 
 
   
   
 
   
   
 
   
       
 
However, McCauley and colleagues (2009) reported no statistically significant 
difference between Caucasian women’ and minority women’s use. Furthermore, 
the researchers reported no significant contribution of education and income. Only 
relationship status yielded a marginally significant difference; however, reasons 
for this are not well understood (Arkes & Iguchi, 2008). Some researchers 
suggested that non-medical prescription drug use was used to self-medicate 
symptoms of anxiety (Woicik, Stewart, Pihl & Conrod, 2009). Furthermore, 
particular concern of non-medical use for pharmaceutics has been expressed, as 
women may use over-the-counter available and prescription medicines 
concurrently, while often diagnosed with comorbid mental health problems 
(National Institute on Drug Abuse, 2011). To date, the issue of pharmaceuticals 
use for non-medical purposes with regard to mental health and other substance 




Women’s non-medical use of pharmaceuticals  
 
Women have been recognised as a particularly vulnerable population group with 





face specific difficulties such as victimisation by an 
intimate partner, and concerns that the involvement of child protection services will 
result in loss of children (Guggisberg, 2010). 
 
Many women engaging in non-
medical use of prescription drugs experience violence or abuse by a current or 
former intimate partner. While the reasons for the non-medical use of 
pharmaceuticals is not well understood, 
 
it has been recognised that this ‘new group’ 
of drug users has particularly complex needs. 
 
For example, non-medical use of pharmaceuticals often occurs in the context of 
mental health problems suggesting an attempt to self-medicate psychiatric 
symptoms  (Sturza & Campbell, 2005) and trauma-related effects (Williamson, 




 Calculated coping 
It has been hypothesised that one possible reason for women to engage in non-
medical use of prescription medication is a way of alleviating painful thoughts and 
feelings about difficulties in their lives, as a form of avoidance. Here the role of 









The addiction literature suggests that women with co-occurring mental health 
problems use prescription drugs as self-medication measures to achieve reduction of 
negative emotions and distress (Guggisberg, 2012). The coping strategy of using 
prescription medication non-medically may be deemed ‘maladaptive’ or 
‘inappropriate’. However, the seriousness of distress experienced that resulted in 
such behaviour must not be trivialised. Women’s personal resources (or lack 
thereof) to cope with life stresses need to be recognised and acknowledged along 
with the fact that their perceived control over the distressing situation may be an 
important maintaining factor. Currently, little is known about individuals’ 
circumstances and motivations to engage in non-medical use of prescription 
medications.  
 
Ryder and colleagues (2006) argued that psychoactive substances are frequently 
consumed in order to increase a person’s ability to cope with certain situations. 
They stated that ‘some drug users say that they have to use their drug of choice 
simply to feel normal’ (p. 12). Therefore, it can be argued that women using 
prescription medications for non-medical purposes may engage in ‘calculated 
coping’. However, given the danger of such behaviours as well as associated health 
risks, it is argued that further research should examine women’s expectancies from 
the use of various prescription medications to explore reinforcement motivations 
and assist in therapy. 
 
Positive expectancies may influence cognitive decision making rationalisations of 
women using prescription medications for non-medical purposes. Previous studies 
found much evidence in support of self-medicating behaviour, namely positive and 
negative reinforcement motives for psychoactive substances including non-medical 
pharmaceuticals use (Bell & Salmone, 2009; Guggisberg, 2010).  
 
 
Concern for children 
Society places specific focus of attention on mothering regardless whether or not a 
woman experiences abuse and/or violence by a current or former intimate partner 
(Peled & Gil, 2011). Feminist scholars continue to criticise the prevalent culture of 
gender inequality and its structural processes (Guggisberg, 2010). The social 
construction of the ‘ideal mother’ is still deeply embedded in contemporary society 
despite political activism in recent decades (Douglas & Michaels, 2004; O’Reilly,  
2010). O’Reilly (2010) asserted that women who are mothers are disproportionately 
victimized by intimate partner violence. 
 
Women in violent relationships who are mothers are facing unique challenges in 
their concern for the wellbeing of their children and the desire to protect them 
(Peled & Gil, 2011). In order to do so, women may choose to stay in an abusive 
and/or violent relationship (Radford & Hester, 2006; Solveig, Vatnar, & Bjorkly, 






   
 
   
   
 
   
   
 
   
        
 
    
 
 
   
   
 
   
   
 
   
       
 
Motherhood is an additional risk factor of negative health outcomes of abused 
women (Solveigh et al., 2010; O’Reilly, 2010). The increased distress of comforting 
children exposed to violence and ensuring their needs are met may pose an 
additional challenge to abused women, who may be affected by mental  
and physical health impacts as a result of exposure to abuse or violence (Peled & 
Gil, 2011).  
 
While research into the effects of mothering capability of victimised women is 
scarce, evidence suggests that the majority of abused mothers is able to parent 
successfully even against the background of continuous victimisation (Radford & 
Hester, 2006). For example, Peled and Gil’s (2010) reported that victimised women 
were most concerned about the wellbeing of their children and reported that “the 
children are above all else and that they must do everything for the sake of the 
children” (Peled & Gil, 2011, p. 464). The study also found that the mothers 
attempted to maintain control by preserving a view of themselves as “good, 
functioning mothers” (p. 466). 
 
Maintaining control 
Some women, it has been reported, accept their victimisation as normal and give 
resistance up over time (Williamson, 2010). They learn to survive while living in 
the situation that is experienced as ‘enforced dependency’ (Herman, 1992, p. 83) in 
which the women become compliant and submissive (Williamson, 2010). They 
often internalise blame placed upon them by the abuser and/or the environment 
(Herman, 1992), a strategy they find useful as they accept responsibility for their 
victimisation and experience a sense of control (Williamson, 2010).  However, the 
distress and continuous danger of ‘walking on egg shells’ may result in self-




An Australian Study 
 
In Australia, little research has investigated the use of non-medical prescription drug 
use (Nicolas, Lee, & Roche, 2011). As part of a larger study, 227 women’s use of 
psychoactive substances including non-medical use of pharmaceuticals was examined 
(for information on methodology and data analysis see Guggisberg, 2010). Adult 
female respondents provided anonymous information on their licit and illicit drug use 
behaviours. Findings are reported here on respondents’ use of painkillers/analgesics 
and/or tranquillisers/sleeping pills with regard to demographic characteristics and co-









Overall, there was some difference between the age groups, and despite statistical 
comparison yielded non-significant results, χ
2
 (4, N = 227) = 1.022, p = .907, 











Of the 227 respondents, 64 (28.2%) reported to have used pharmaceutics, either 
painkillers/analgesics (P/A) or tranquillisers/sleeping pills (T/S), for non-medical 
purposes in the 12 months prior to completing the questionnaire. Approximately one 
in three of these women reported to have used both, P/A and T/S.   
 
Generally, a slight increase of painkillers/analgesics use with increasing age was 
observed. Young women aged 18 - 25 years used painkillers/analgesics at a higher 
rate (27%) than those in the age group 35 – 46 years (21%), from which an increase 
could be observed until over 29% among women aged between 56 – 65 years. 
Overall, results suggested little fluctuation among the age categories with regard to 
painkillers/analgesics.  
 
By comparison, the trend for the use of tranquillisers/sleeping pills suggested a 
steady decrease with age until 55 years. As with painkillers/analgesics, the 
prevalence was highest among 18 - 25 year olds and lowest for over 45 year olds 
with about 9%, and a minimal increase to less than 12% at age 56-65 years. 
 
These results suggest that the non-medical use of painkillers/analgesics appeared to 
be relatively stable with little fluctuation regardless of age, whereas with increasing 
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Other demographic characteristics 
An examination of relationship status suggested that women using pharmaceuticals 
for non-medical purposes were most likely to be married/cohabiting (65%) and least 
likely to be in a dating relationship (18%). Married women were slightly more likely 
to use painkillers/analgesics than cohabiting women, while cohabiting women were 
more likely to use tranquillisers/sleeping pills. One in four women currently 
separated, used pharmaceutics for non-medical purposes. Women in this category 
were more likely to use P/A than T/S for non-medical purposes. The lowest 
prevalence was found among women in dating relationships. Women in this category 
were more likely to use P/A.  
 
With regard to Indigenous status, the study found that the rate of pharmaceuticals 
use for non-medical purposes was approximately 2:1 with Aboriginal women nearly 
twice as likely to report past-year use when compared to non-Aboriginal women. 
However, regardless of this characteristic, women in both categories were more likely 
to use P/A than T/S. 
 
Education level did not appear to influence use of pharmaceuticals for non-medical 
purposes much. Women with less than year 10 completed, were slightly less likely 
to engage in non-medical use pharmaceuticals when compared to those with at least 
10 years of completed formal education.  
 
Similarly, gross weekly income did not reveal different use patterns. Respondents 
reporting income between $600 and $999 were slightly more likely (30%) than 
those earning less than $600 (27%) or over $1000 per week (25%) to use P/A and/or 
T/S. The use of P/A was higher than the use of T/S in all categories. Participation in 




Co-occurring mental health problems 
Women using pharmaceuticals for non-medical purposes were identified with 
mental health problems. Nearly 21% of participants aged 18 – 25 years reported co-
occurring anxiety with the use of non-medical pharmaceuticals use. The highest 
prevalence of 22.2% was found among women aged 36 – 45 years, while the lowest 
prevalence of 16.3% was found among women aged between 26 and 35 years. 
Women aged between 36 – 45 years also had the highest prevalence of PTSD co-












Furthermore, co-occurring mental health problems were reported by 23.5% of 
women who experienced violence by a current or previous male intimate partner, 
which was significantly lower for those with no exposure to violence (7.5%). 
Additionally, anxiety-related use of pharmaceuticals for non-medical purposes was 










P&A = Pharmaceuticals use for non-medical purposes co-occurring with anxiety; 
P&D = Pharmaceuticals use for non-medical purposes co-occurring with 
depression; P&PTSD = Pharmaceuticals use for non-medical purposes co-
occurring with PTSD. 
 
Figure 2 shows that overall, the co-occurrence of pharmaceuticals use for non-
medical purposes with PTSD tended to decrease with increasing age with the 
exception of the age category 36 – 45 years. Middle aged women appeared to be 
most likely to suffer anxiety as well as PTSD in combination with pharmaceuticals 
use for non-medical purposes, while also being least likely to suffer depression in 
combination with pharmaceuticals use for non-medical purposes. Women aged 
between 56 years and 65 years were most likely to use pharmaceuticals for non-
medical purposes if they experienced anxiety or depression, but least likely to use 
pharmaceuticals for non-medical purposes if they experienced PTSD. These 
results suggest that respondents were most likely to engage in the use of 





















   
 
   
   
 
   
   
 
   
        
 
    
 
 
   
   
 
   
   
 
   
       
 
Other demographic characteristics 
With regard to status of relationship, it was observed that separated, married and 
cohabiting women were most likely affected by anxiety and use of pharmaceuticals 
for non-medical purposes. Female respondents were less likely to utilise 
pharmaceuticals for non-medical purposes when experiencing depression or PTSD  
in comparison with anxiety. Overall, separated women had the highest prevalence 
of pharmaceuticals use co-occurring with mental health problems, while women in 
dating relationships had the lowest prevalence. Contrary to other types of 
psychoactive substances (Guggisberg, 2010), marriage did not appear to be a 
protective factor with the use of pharmaceuticals for non-medical purposes 
comorbid with mental health issues.  
 
An examination of Indigenous status revealed that prevalence anxiety-related use 
of pharmaceuticals for non-medical purposes was substantially higher among 
Aboriginal women when compared to non-Aboriginal women (30.0% vs. 19.8%). 
With regard to PTSD, Aboriginal women were statistically significantly more likely 
to use pharmaceuticals for non-medical purposes when compared to non-Aboriginal 
respondents. No differences were observed with regard to depression (10.0% vs. 
11.5%).  
 
A higher level of education did not appear to influence the occurrence of 
pharmaceuticals use for non-medical purpose in this sample. While women with at 
least year 10 completed experienced slightly higher prevalence of co-occurring 
anxiety and non-medical use of pharmaceuticals when compared to women with 
less than 10 years of formal education, Chi-square analyses suggested non-
significant results. 
 
Women with a completed qualification were less likely to report use of 
pharmaceuticals for non-medical purposes for all three types of mental health 
problems when compared with women not holding a completed qualification. 
Not surprisingly then, respondents with a gross weekly income level of at 
least $1000  were least likely to report using of pharmaceuticals for non-
medical purposes for all types of mental health problem. However, statistical 
analysis yielded a non-significant influence of gross weekly income. 
 
Summary of findings 
In summary, this study found interesting patterns with regard to socio-demographic 
characteristics involving mental health problems co-occurring with the use of 
pharmaceuticals for non-medical purposes. Women with anxiety used 
pharmaceuticals at a rate of around 20% in all age groups. With regard to 
depression it was found that women in the age category 56 – 65 years had the 
highest prevalence. Aboriginal women were more likely to use pharmaceuticals for 







Indigenous status was minimal with depression. Education level and qualification 
did also not appear to demonstrate a clear pattern. Co-occurring mental health 
problems were found to be higher in women with no completed qualification, 
particularly in relation to anxiety. As with other forms of psychoactive substances, 
women with a weekly gross income level of at least $1000 were least likely to be 
affected. Workforce participation did not seem to make a difference with regard to 
mental health problems and use of pharmaceuticals for non-medical purposes. 
 
These findings suggest that women with certain backgrounds are at a higher risk of 
engaging in non-medical use of pharmaceuticals. To reduce harm and prevent 
adverse outcomes, it is essential to have knowledge and understanding of 
contributing factors as well as ways in which pharmaceuticals can be ‘abused’. 
 
 
Reducing harm and preventing adverse outcomes 
 
Assisting individuals who present with non-medical use of pharmaceuticals is 
usually challenging (Gonzales, Brecht, Mooney, & Rawson, 2011). Often, 
underreporting is a problem due to embarrassment and fear. However, discussion 
is required to ensure safety.  
 
For clinicians, it is important to recognise non-medical use of prescription 
medication. There are numerous ways by which prescription medications are 
‘abused’. These include the following: 
 
 Using prescribed medication at a higher dose than prescribed 
 Using somebody else’s prescribed medications 
 Using prescription medications in combination with other substances       
            (without the knowledge of the medical practitioner) 
 Using medication by a different route of administration than prescribed 
 
Medical practitioners, counsellors and other health professionals may identify 
non-medical use of medication and prevent escalation by asking specific 
questions about a patient’s use of the prescribed drugs (Lessenger & Feinberg, 
2008). For example, it may be enquired whether she/he complies with prescribed 
doses and/or if other, over-the-counter available medications are taken to ‘top up’ 
the prescriptions. Furthermore, it should be noted that often, individuals with 
prescription drug use problems engage in ‘doctor shopping’ behaviours, which is, 
obtaining multiple prescriptions at the same time from different doctors. 
Consequently, asking whether prescription medications are taken as directed and 
being aware of the possibility of ‘topping up’ and ‘doctor shopping’ may be 
effective avenues to engage in the discussion of the hidden danger of non-medical 
use of prescription drugs in general, and with female patients who present with 
complex problems in particular. 
 
 
   
 
   
   
 
   
   
 
   
        
 
    
 
 
   
   
 
   
   
 
   
       
 
As mentioned above, understanding should be demonstrated for maladaptive coping 
and sensitive enquiries made as to the reasons for utilising prescription medications as a  
strategy to regulate emotional distress.  Being able to recognise addiction is not easy.  
 
However, indications involve explanations such as losing a prescriptions or 
medications, report theft, exaggerating pain symptoms and request particular 





In conclusion, concern about the non-medical use of pharmaceuticals has 
increased in recent years. Individuals caught up in such drug using behaviour may 
have particularly complex needs. It appears imperative to not only raise awareness 
among practitioners, the public, and policy makers of this emerging problem, but 
also to ensure that treatment options are appropriate. This requires increased 
readiness to engage in multidisciplinary collaborative care. There appears to be a 
necessity to extend concern about psychoactive substances to pharmaceuticals that 
can be used not only legitimately but for non-medical purposes. Marked 
similarities have been noted to those substances already ‘on the radar’ such as 
alcohol, tobacco, and illicit drugs. The continuous availability of pharmaceuticals 
over the counter may exacerbate the problem of non-medical use of 
pharmaceuticals. It appears imperative raising awareness among practitioners, the 
public and policy makers to ensure treatment options are appropriate and 
evidence-based. 
 
Physicians, their patients, and pharmacists can all play a role in identifying and 
preventing non-medical use of prescription drugs, placing them in a unique 
position, not only to prescribe medications, but also to identify abuse (or 
nonmedical use) of prescription drugs and prevent the escalation to addiction. By 
asking about all drugs, physicians can help their patients recognize that a problem 
exists, set recovery goals, and seek appropriate treatment make appropriate 
referrals to an alcohol and other drug treatment agency. 
 
While treating prescription drug addiction is difficult, the first step is recognising 
the problem and addressing it with the patient and making a referral to an alcohol 
and/or other drugs counsellor pharmacotherapy options such as the use of 
buprenorphine and/or naltrexone. This may be the first step in preventing 
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